Joslin Diabetes Center and Humedica Launch Strategic Collaboration to Improve Quality and Efficiency of Care and Prevention Efforts for Diabetes

Tools

Leveraging de-identified patient health information to explore variations in diabetes care and offer providers clinically relevant interventions to improve outcomes

Joslin Diabetes Center and Humedica Launch Strategic Collaboration to Improve Quality and Efficiency of Care and Prevention Efforts for Diabetes

<0> HumedicaPatricia Kellicker, 617-475-3899orJoslin Diabetes CenterJeff Bright, 617-309-1957 </0>

Joslin Diabetes Center, an affiliate of Harvard Medical School, has joined forces with Humedica to redefine traditional models of continuing medical education (CME) by leveraging Humedica’s de-identified clinical data assets and offering providers an opportunity to participate in education or research activities designed to improve care based on identified gaps.

The collaboration is kicking off with a series of innovative projects, each starting with a baseline analysis of retrospective real-world practice patterns of patients with type 2 diabetes. Each analysis includes both process measures and patient outcomes data. Initial topics include:

I. Comparison of data methods for assessing physicians’ practice patterns

II. Improving clinician proficiency in insulin initiation and management

III. Examining barriers to optimal care of patients with post-prandial glycemia

John Brooks, President and Chief Executive Officer of Joslin says, "Big data provides a new frontier to drive health care quality improvements, and Humedica is well positioned to support Joslin in our ongoing efforts to positively impact diabetes care through data analytics and clinical support driven initiatives.”

Michael Weintraub, Humedica’s President and CEO, adds, “Working with Joslin is a natural fit for us. Supporting research that examines and improves the way healthcare is delivered is an extension of the value we create for our providers today - transforming clinical data into actionable insights and meaningful results.”

Humedica will be providing Joslin’s researchers access to a de-identified clinically robust, population health data set, and coordinating with their partner, the American Medical Group Association (AMGA) to engage providers to participate in performance focused CME or other research initiatives. Current projects are supported via independent educational grants from Sanofi, Pfizer, GlaxoSmithKline and Lilly.

“This is the new direction for continuous quality improvement,” adds Julie Brown, CCMEP, director of professional education at Joslin. “Through the combination of Humedica’s clinical data and provider network, and Joslin’s performance focused CME program, we are able for the first time to efficiently leverage actual clinical performance and outcomes so we can better understand physicians’ unmet needs in diabetes and cardiometabolic health. Only then can we prospectively address these gaps through targeted interventions. This data-education combination will position continuing medical education where it belongs - at the center of medical practice where it can be used as a tool to enhance quality and value.”

ABOUT HUMEDICA

is the foremost clinical intelligence company that provides private cloud based business solutions to the health care industry. Humedica’s sophisticated analytics platform transforms disparate clinical data into actionable, real world insights. Powered by the largest and most comprehensive clinical database, Humedica solutions move beyond claims data to offer a more complete, longitudinal view of the patient population. Through its award-winning solutions, Humedica which is headquartered in Boston, empowers its partners and customers to make confident, value-based decisions about patient care in a rapidly changing health care market. For more information, visit . Connect with Humedica on Twitter @humedicainc and Facebook at .

ABOUT JOSLIN DIABETES CENTER

Joslin Diabetes Center, located in Boston, Massachusetts, is the world's largest diabetes research and clinical care organization. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure. Joslin is an independent, nonprofit institution affiliated with Harvard Medical School. Joslin Professional Education, established in 1990, was recently re-awarded Accreditation with Commendation- the highest level available, by the ACCME as a provider of medical education. Joslin's unique performance-focused programs serve more than 20,000 primary care and specialty providers annually. For more information visit